文献速递心力衰竭与心肌病心律失常冠心病

靶向钙调控治疗心力衰竭与心律失常:关键综述

Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review.
PubMed 文献 · Circulation · 2025-09-29

该综述探讨心肌细胞钙处理异常作为心衰及房性、室性心律失常的核心致病机制,评估钙处理蛋白相关研究现状与治疗意义,并分析近期范式转变发现、临床试验结果及靶向钙处理蛋白的挑战。

要点

  • 心肌细胞钙处理缺陷是心衰与心律失常的核心致病机制
  • 靶向钙处理蛋白的治疗策略需基于蛋白在健康与疾病中的差异表达和功能
  • 近期范式转变发现与临床试验结果对开发钙靶向治疗至关重要

核心结论

  • 深入理解钙处理蛋白在人体健康与疾病中的差异表达和功能,对开发能根本改变心衰与心律失常自然史的治疗至关重要。

研究设计与样本

  • 综述类文章,检索范围未在摘要中明确报告。

主要发现

  • 心肌细胞钙处理缺陷被认定为心衰及房性和室性心律失常的核心致病机制。
  • 综述评估了钙处理蛋白相关研究现状及其治疗意义。
  • 综述分析了近期范式转变发现、临床试验结果及靶向钙处理蛋白的挑战。

临床怎么用

  • 临床应关注钙处理蛋白作为心衰和心律失常治疗靶点的潜力。
  • 靶向钙处理蛋白的治疗开发需考虑蛋白在健康与疾病中的差异表达和功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite advances in pharmacologic and procedural therapies, heart failure (HF) and cardiac arrhythmias remain significant global health burdens, highlighting the urgent need for novel therapeutic strategies. Defective Ca2+ handling in cardiac myocytes is recognized as a central pathogenic mechanism underlying both heart failure and atrial and ventricular arrhythmias. In this review, we critically assess the current state of research on Ca2+-handling proteins and their role in causing heart failure and arrhythmias, highlighting therapeutic implications. Recent paradigm-shifting discoveries, clinical trial outcomes, and challenges of targeting Ca2+-handling proteins are examined. As outlined in this review, an improved understanding of the relevant proteins and their differential expression and function in human health and disease is crucial for developing Ca2+ handling-targeted therapeutics that can fundamentally alter the natural history of heart failure and arrhythmias.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Redel-Traub, Marx, Marks, et al. Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review. Circulation. 2025. PMID: 41021670. doi:10.1161/CIRCULATIONAHA.125.075150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。